Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine
- PMID: 31492022
- PMCID: PMC6770961
- DOI: 10.3390/genes10090682
Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine
Abstract
The increasing availability of high throughput proteomics data provides us with opportunities as well as posing new ethical challenges regarding data privacy and re-identifiability of participants. Moreover, the fact that proteomics represents a level between the genotype and the phenotype further exacerbates the situation, introducing dilemmas related to publicly available data, anonymization, ownership of information and incidental findings. In this paper, we try to differentiate proteomics from genomics data and cover the ethical challenges related to proteomics data sharing. Finally, we give an overview of the proposed solutions and the outlook for future studies.
Keywords: data; genomics; personal medicine; privacy; proteomics; re-identifiability.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Zaveri A., Ertaylan G. Linked Data for Life Sciences. Algorithms. 2017;10:126. doi: 10.3390/a10040126. - DOI
-
- Jain K.K. Role of Proteomics in the Development of Personalized Medicine. Met. Contain. Enzym. 2016;102:41–52. - PubMed
-
- Bunk E.C., Ertaylan G., Ortega F., Pavlou M.A., Cano L.G., Stergiopoulos A., Safaiyan S., Völs S., Van Cann M., Politis P.K., et al. Prox1 Is Required for Oligodendrocyte Cell Identity in Adult Neural Stem Cells of the Subventricular Zone. Stem Cells. 2016;34:2115–2129. doi: 10.1002/stem.2374. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources